Congratulations to Drs. Denis Bouchard, Nicolas Dürrleman, and the Montreal Heart Institute team on Canada’s first AtriClip FLEX-Mini® case. This milestone brings a new option for LAAE into open concomitant practice.
 
Discover more: <a href="https://t.co/Tuzg4lpEVh&quot; target="_blank">https://t.co/Tuzg4lpEVh</a&gt;
<a href="https://twitter.com/hashtag/AtriClip?src=hashtag_click&quot; target="_blank">#AtriClip</a>

Congratulations to Dr. Denis Bouchard, Dr. Nicolas Dürrleman and the Montreal Heart Institute team on successfully incorporating the AtriClip FLEX-Mini® device into their open concomitant practice. As the first case in Canada, this milestone expands options for left atrial appendage exclusion (LAAE) in open cardiac surgery.

Discover more: <a href="https://okt.to/LXzZil&quot; target="_blank">https://okt.to/LXzZil</a&gt;
<a href='https://www.linkedin.com/feed/hashtag/?keywords=AtriClip&highlightedUpd…; target='_blank'>#AtriClip</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=LAAExclusion&highlighte…; target='_blank'>#LAAExclusion</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>

We’re proud to share that 100,000 patients have been treated with a device from the cryoSPHERE family for post-op pain management. Cryo Nerve Block technology is being used by surgeons globally as part of a multimodal approach.

Discover more: <a href="https://t.co/8O7la8RdCw&quot; target="_blank">https://t.co/8O7la8RdCw</a&gt;

<a href="https://twitter.com/hashtag/cryoNB?src=hashtag_click&quot; target="_blank">#cryoNB</a>

Every patient and every recovery matters. We’re proud to share that 100,000 patients have been treated with a device from the cryoSPHERE family for post-operative pain management.

For many patients, pain can be a significant challenge during recovery. Cryo Nerve Block technology is being used by surgeons around the world as part of a multimodal approach for changing outcomes.

Discover more: <a href="https://okt.to/OlRSLy&quot; target="_blank">https://okt.to/OlRSLy</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=cryoNB&highlightedUpdat…; target='_blank'>#cryoNB</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a>

161,000 CABG patients each year. 1 in 5 with Afib. Nearly 90% untreated.

Fixing arteries isn’t enough when rhythm and long-term risk remain unaddressed.

Join us at <a href="https://twitter.com/hashtag/STS2026?src=hashtag_click&quot; target="_blank">#STS2026</a> to learn more about restoring sinus rhythm or by visiting: <a href="https://t.co/0zfpq2MUF5&quot; target="_blank">https://t.co/0zfpq2MUF5</a&gt;

<a href="https://twitter.com/hashtag/Afib?src=hashtag_click&quot; target="_blank">#Afib</a> <a href="https://twitter.com/hashtag/CABG?src=hashtag_click&quot; target="_blank">#CABG</a>

161,000 CABG patients each year. 1 in 5 with Afib. Nearly 90% untreated.

Fixing arteries isn’t enough when rhythm and long-term risk remain unaddressed.

Every CABG patient with Afib deserves rhythm restoration.

Join us at <a href='https://www.linkedin.com/feed/hashtag/?keywords=STS2026&highlightedUpda…; target='_blank'>#STS2026</a> to learn more about restoring sinus rhythm or by visiting: <a href="https://okt.to/nZINwk&quot; target="_blank">https://okt.to/nZINwk</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CABG&highlightedUpdateU…; target='_blank'>#CABG</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>

Here’s to 2026! A new year to collaborate, innovate, and advance Afib treatment and post-op pain management for patients around the globe. Happy New Year!​ <a href="https://www.facebook.com/hashtag/HappyNewYear&quot; target="_blank">#HappyNewYear</a>

Hybrid AF™ Therapy with the EPi-Sense System is the first &amp; ONLY FDA-approved device for minimally invasive ablation therapy to treat LSPAF—the most prevalent and undertreated Afib patient population. ​Discover the EPi-Sense ST™ device: <a href="https://t.co/zOeFodmoXQ&quot; target="_blank">https://t.co/zOeFodmoXQ</a&gt; ​

<a href="https://twitter.com/hashtag/Afib?src=hashtag_click&quot; target="_blank">#Afib</a>

Hybrid AF™ Therapy with the EPi-Sense System is the first and ONLY FDA-approved device for minimally invasive ablation therapy to treat long-standing persistent Afib—the most prevalent and undertreated Afib patient population.​​
​
Discover the EPi-Sense ST™ device: <a href="https://okt.to/Wpznxd&quot; target="_blank">https://okt.to/Wpznxd</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>

The AriClip Mini offers a low-profile, closed-ended design, providing complete isolation of the left atrial appendage. ​​

Discover the latest AtriClip innovation: <a href="https://t.co/hqmodR5KGb&quot; target="_blank">https://t.co/hqmodR5KGb</a&gt; ​

<a href="https://twitter.com/hashtag/AtriClip?src=hashtag_click&quot; target="_blank">#AtriClip</a> <a href="https://twitter.com/hashtag/LAAE?src=hashtag_click&quot; target="_blank">#LAAE</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>